Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Megna

Showing results (91-100 of 381) with videos related to

Pageof 39
Sort By:
Skin Appendage Disorders|December 14, 2020
Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HSAngelo Ruggiero, Gabriella Fabbrocini, Matteo Megna, et al.
Dermatologic Therapy|June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life settingMatteo Megna, Luca Potestio, Elisa Camela, et al.
Italian Journal of Dermatology and Venereology|November 12, 2020
A 16-year real-life study on the prevalence of mycoses in a pediatric populationMariatresa Nocerino, Eleonora Cinelli, Matteo Megna, et al.
Psoriasis (Auckland, N.Z.)|June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current KnowledgeAngelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Journal of the American Academy of Dermatology|August 10, 2022
Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study"Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Expert Opinion on Biological Therapy|August 15, 2022
New frontiers in personalized medicine in psoriasisElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology|August 27, 2024
Lichen planus following COVID-19 vaccination: a narrative reviewMichela D'Agostino, Fabrizio Martora, Matteo Megna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 16, 2023
Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by GambichlerLuca Potestio, Fabrizio Martora, Alessia Villani, et al.
Clinical and Experimental Dermatology|May 8, 2024
Author reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?'Luca Potestio, Matteo Megna, Sara Cacciapuoti, et al.
Clinical and Experimental Dermatology|May 8, 2024
CorrespondenceAuthor reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?' by Duff et alLuca Potestio, Matteo Megna, Sara Cacciapuoti, et al.
Pageof 39

Showing results (91-100 of 381) with videos related to

Sort By:
Pageof 39
Skin Appendage Disorders|December 14, 2020
Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HSAngelo Ruggiero, Gabriella Fabbrocini, Matteo Megna, et al.
Dermatologic Therapy|June 28, 2022
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life settingMatteo Megna, Luca Potestio, Elisa Camela, et al.
Italian Journal of Dermatology and Venereology|November 12, 2020
A 16-year real-life study on the prevalence of mycoses in a pediatric populationMariatresa Nocerino, Eleonora Cinelli, Matteo Megna, et al.
Psoriasis (Auckland, N.Z.)|June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current KnowledgeAngelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Journal of the American Academy of Dermatology|August 10, 2022
Reply to "Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study"Angelo Ruggiero, Luca Potestio, Elisa Camela, et al.
Expert Opinion on Biological Therapy|August 15, 2022
New frontiers in personalized medicine in psoriasisElisa Camela, Luca Potestio, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology|August 27, 2024
Lichen planus following COVID-19 vaccination: a narrative reviewMichela D'Agostino, Fabrizio Martora, Matteo Megna, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 16, 2023
Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by GambichlerLuca Potestio, Fabrizio Martora, Alessia Villani, et al.
Clinical and Experimental Dermatology|May 8, 2024
Author reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?'Luca Potestio, Matteo Megna, Sara Cacciapuoti, et al.
Clinical and Experimental Dermatology|May 8, 2024
CorrespondenceAuthor reply to 'Comment on ChatGPT and medical writing in dermatology: why should we keep writing?' by Duff et alLuca Potestio, Matteo Megna, Sara Cacciapuoti, et al.
Pageof 39